Our finding that IRF3 phosphorylation is decreased in AD, combined with our finding that oligomerization of p53 is inhibited in AD, suggests that a similar mechanism could explain the observed effects on STING and interferon. This evidence concerns the gene IRF3 and Alzheimer disease.